These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
738 related articles for article (PubMed ID: 18937970)
21. Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study. Gemer O; Gdalevich M; Voldarsky M; Barak F; Ben Arie A; Schneider D; Levy T; Anteby EY; Lavie O Eur J Surg Oncol; 2009 Aug; 35(8):865-9. PubMed ID: 19013746 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848 [TBL] [Abstract][Full Text] [Related]
23. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112 [TBL] [Abstract][Full Text] [Related]
24. Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment. Phelan C; Montag AG; Rotmensch J; Waggoner SE; Yamada SD; Mundt AJ Gynecol Oncol; 2001 Dec; 83(3):513-7. PubMed ID: 11733964 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of gross myometrial invasion with endometrial cancer. Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246 [TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898 [TBL] [Abstract][Full Text] [Related]
27. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma. Madom LM; Brown AK; Lui F; Moore RG; Granai CO; Disilvestro PA Gynecol Oncol; 2007 Oct; 107(1):75-8. PubMed ID: 17629550 [TBL] [Abstract][Full Text] [Related]
28. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095 [TBL] [Abstract][Full Text] [Related]
29. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer. Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481 [TBL] [Abstract][Full Text] [Related]
30. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer. Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392 [TBL] [Abstract][Full Text] [Related]
31. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Lachance JA; Everett EN; Greer B; Mandel L; Swisher E; Tamimi H; Goff B Gynecol Oncol; 2006 Jun; 101(3):470-5. PubMed ID: 16413048 [TBL] [Abstract][Full Text] [Related]
32. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Briët JM; Hollema H; Reesink N; Aalders JG; Mourits MJ; ten Hoor KA; Pras E; Boezen HM; van der Zee AG; Nijman HW Gynecol Oncol; 2005 Mar; 96(3):799-804. PubMed ID: 15721428 [TBL] [Abstract][Full Text] [Related]
33. Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size. Fotiou S; Vlahos N; Kondi-Pafiti A; Zarganis P; Papakonstantinou K; Creatsas G Gynecol Oncol; 2009 Mar; 112(3):517-20. PubMed ID: 19117598 [TBL] [Abstract][Full Text] [Related]
34. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498 [TBL] [Abstract][Full Text] [Related]
35. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648 [TBL] [Abstract][Full Text] [Related]
36. The grading of lymphovascular space invasion in endometrial carcinoma. Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436 [TBL] [Abstract][Full Text] [Related]
37. [Clinical implications of positive peritoneal cytology in endometrial cancer]. Ren YL; Wang HY; Shan BE; Ping B; Shi DR Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518 [TBL] [Abstract][Full Text] [Related]
38. Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study. Saatli B; Olgan S; Gorken IB; Uslu T; Saygili U; Dicle N; Cingillioglu B; Gumurdulu D; Guzel AB; Koyuncuoglu M Arch Gynecol Obstet; 2014 Jun; 289(6):1331-5. PubMed ID: 24435497 [TBL] [Abstract][Full Text] [Related]
39. Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence. Hétu V; Petignat P; Wu Y; Drouin P; Sauthier P; Provencher D; Gauthier P Gynecol Obstet Invest; 2009; 67(3):173-7. PubMed ID: 19088481 [TBL] [Abstract][Full Text] [Related]
40. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]